**Question:** MYC gene is

A. proto-oncogene
B. tumor suppressor gene
C. transcription factor
D. DNA repair gene

**Correct Answer:** C. transcription factor

**Core Concept:** The MYC gene is a crucial component in cellular regulation and is classified as a **transcription factor**. Transcription factors are proteins that bind to DNA and regulate gene expression, either by activating or inhibiting the transcription of a target gene.

**Why the Correct Answer is Right:** In the case of the MYC gene, it belongs to the family of basic helix-loop-helix-leucine zipper (bHLHZip) transcription factors. The MYC protein regulates various cellular processes, including cell growth, proliferation, and differentiation. It plays a significant role in cellular response to growth factors, cytokines, and other extracellular signals. Mutations in the MYC gene can lead to uncontrolled cell growth, contributing to tumor development and progression.

**Why Each Wrong Option is Incorrect:**

A. **Proto-oncogene:** While proto-oncogenes are also involved in cellular regulation, they are not transcription factors but rather contribute to cell division and differentiation. Unlike MYC, proto-oncogenes are not typically mutated in cancer.

B. **Tumor suppressor gene:** Tumor suppressor genes, such as TP53, are responsible for preventing uncontrolled cell growth and preventing cancer development. MYC, on the other hand, is not a tumor suppressor gene but rather contributes to tumorigenesis when mutated or overexpressed.

D. **DNA repair gene:** MYC does not participate in DNA repair processes, which are primarily regulated by genes involved in maintaining genomic stability and repairing DNA damage. MYC is a transcription factor regulating cellular processes but not directly involved in DNA repair mechanisms.

**Clinical Pearl:** Understanding the role of MYC and its association with cellular regulation and cancer development is crucial for medical professionals, particularly oncologists and hematologists, as it helps in diagnosing, treating, and predicting the prognosis of various cancers, such as Burkitt's lymphoma and some types of leukemia. In addition, MYC overexpression is used as a marker for high-grade malignancies and can guide treatment decisions based on molecular profiling of tumors.